Immuneering Co. (NASDAQ:IMRX) Director Purchases $63,750.00 in Stock

Immuneering Co. (NASDAQ:IMRX – Get Free Report) Director Peter Feinberg acquired 25,000 shares of the firm’s stock in a transaction on Friday, March 22nd. The shares were bought at an average cost of $2.55 per share, for a total transaction of $63,750.00. Following the completion of the acquisition, the director now directly owns 111,766 shares […]

Related Keywords

Peter Feinberg ,Immuneering Company Profile ,Virtu Financial ,Nuveen Asset Management ,Immuneering Corporation ,Nasdaq ,Vanguard Group Inc ,Securities Exchange Commission ,Jefferies Financial Group ,Oracle Alpha Inc ,Immuneering Co ,Needham Company ,Barclays Plc ,Get Free Report ,Director Peter Feinberg ,Exchange Commission ,Stock Down ,Asset Management ,Oracle Alpha ,Financial Group ,Chardan Capital ,Investigational New Drug ,Immuneering Daily ,Immuneering ,Nasdaq Imrx ,Imrx ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,